Novel orally active inhibitors of β-1,3-glucan synthesis derived from enfumafungin-Reference-Cited by-同舟云学术

Novel orally active inhibitors of β-1,3-glucan synthesis derived from enfumafungin

Published:2015-12 Issue:24 Volume:25 Page:5813-5818
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Apgar James M.,Wilkening Robert R.,Greenlee Mark L.,Balkovec James M.,Flattery Amy M.,Abruzzo George K.,Galgoci Andrew M.,Giacobbe Robert A.,Gill Charles J.,Hsu Ming Jo,Liberator Paul,Misura Andrew S.,Motyl Mary,Nielsen Kahn Jennifer,Powles Maryann,Racine Fred,Dragovic Jasminka,Habulihaz Bahanu,Fan Weiming,Kirwan Robin,Lee Shu,Liu Hao,Mamai Ahmed,Nelson Kingsley,Peel Michael

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference27 articles.

1. Fungal Infections

2. Emerging drugs and vaccines for Candidemia

3. Invasive candidiasis: update on current pharmacotherapy options and future perspectives

4. Therapy for fungal diseases: opportunities and priorities

5. Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Fks1 proteins for novel antifungal drug discovery;Trends in Pharmacological Sciences;2024-04

2. Natural Enfumafungin Analogues from Hormonema carpetanum and Their Antifungal Activities;Journal of Natural Products;2023-10-19

3. Macrophage metabolism in nonalcoholic fatty liver disease;Frontiers in Immunology;2023-10-04

4. Ten decadal advances in fungal biology leading towards human well-being;Fungal Diversity;2022-09

5. The Latest FDA-Approved Pharmaceuticals Containing Fragments of Tailor-Made Amino Acids and Fluorine;Pharmaceuticals;2022-08-14